Development of a scoring system for predicting the severity of ulcerative colitis

Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis

(2022) So Imakiire et al.   Gut and Liver

Combination of serological biomarkers and clinical features to predict mucosal healing in Crohn’s disease: a multicenter cohort study

(2022) Nana Tang et al.   BMC GASTROENTEROLOGY

A practical guide for faecal calprotectin measurement: myths and realities

(2020) Ferdinando D’Amico et al.   Journal of Crohns & Colitis

IL-10 enhances T cell survival and is associated with faster relapse in patients with inactive ulcerative colitis

(2020) Shaoxuan Wang et al.   MOLECULAR IMMUNOLOGY

Serological Assessment of the Quality of Wound Healing Processes in Crohn’s Disease

(2019) Shu Sun et al.   Journal of Gastrointestinal and Liver Diseases

Endoscopic score vs blood cell indices for determining timing of immunomodulator withdrawal in quiescent ulcerative colitis

(2019) Kazuhiro Takenaka et al.   Scientific Reports

Diagnostic and clinical role of serum proteinase 3 antineutrophil cytoplasmic antibodies in inflammatory bowel disease

(2018) Hidetoshi Takedatsu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Limited uptake of ulcerative colitis “treat-to-target” recommendations in real-world practice

(2018) Robert V Bryant et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Fecal calprotectin is not superior to serum C-reactive protein or the Harvey–Bradshaw index in predicting postoperative endoscopic recurrence in Crohn’s disease

(2018) Cristina Verdejo et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease

(2016) Lillian Du et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Blood-based Biomarkers Used to Predict Disease Activity in Crohnʼs Disease and Ulcerative Colitis

(2015) Robert Burakoff et al.   INFLAMMATORY BOWEL DISEASES

Disease Activity Assessment in IBD

(2015) James D. Falvey et al.   INFLAMMATORY BOWEL DISEASES

An Evaluation of the Correlation between Hepcidin Serum Levels and Disease Activity in Inflammatory Bowel Disease

(2015) Zehra Betül Paköz et al.   Gastroenterology Research and Practice

PR3-ANCA: A promising biomarker for ulcerative colitis with extensive disease

(2013) Michael Mahler et al.   CLINICA CHIMICA ACTA

Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

(2013) Simon P.L. Travis et al.   GASTROENTEROLOGY

Neopterin Is a Novel Reliable Fecal Marker as Accurate as Calprotectin for Predicting Endoscopic Disease Activity in Patients with Inflammatory Bowel Diseases

(2013) Stephane Nancey et al.   INFLAMMATORY BOWEL DISEASES

The Role of Autoantibodies in Inflammatory Bowel Disease

(2012) László Herszényi et al.   DIGESTIVE DISEASES

Biomarkers in inflammatory bowel disease: current practices and recent advances

(2012) Heba N. Iskandar et al.   Translational Research

Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review

(2011) Lani Prideaux et al.   INFLAMMATORY BOWEL DISEASES

Inflammatory Bowel Disease

(2010) Arthur Kaser et al.   Annual Review of Immunology

World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010

(2009) Charles N. Bernstein et al.   INFLAMMATORY BOWEL DISEASES

Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD)

(2008) Michelle Trevisin et al.   JOURNAL OF IMMUNOLOGICAL METHODS